Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Heidelberg University
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Feasibility judged by number of questions answered by each patient on each treatment day
Study Overview
Brief Summary
The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Device Feasibility
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target
- •Karnofsky performance score (KPS) ≥ 70%,
- •Ability to initiate the therapy as an outpatient
- •≥ 18 years of age
Exclusion Criteria
- •Inability to give informed consent
Arms & Interventions
Mobile application
Patients undergoing radiotherapy will receive additional therapy support by an application installed on a mobile device
Intervention: mobile application (Other)
Outcomes
Primary Outcomes
Feasibility judged by number of questions answered by each patient on each treatment day
Time Frame: 12-14 weeks
Feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day
Secondary Outcomes
- Treatment-related patient satisfaction(12-14 weeks)
- Diagnosis-related Quality of Life(12-14 weeks)
Investigators
Nils Nicolay, PD Dr. Dr.
PD Dr. Dr. Nils Nicolay
Heidelberg University